Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease
Original Article
R.J. Bateman, J. Smith, M.C. Donohue, P. Delmar, R. Abbas, S. Salloway, J. Wojtowicz, K. Blennow, T. Bittner, S.E. Black, G. Klein, M. Boada, T. Grimmer, A. Tamaoka, R.J. Perry, R.S. Turner, D. Watson, M. Woodward, A. Thanasopoulou, C. Lane, M. Baudler, N.C. Fox, J.L. Cummings, P. Fontoura, and R.S. Doody
N Engl J Med 2023;389:1862-1876
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation